ClinicalTrials.gg
Active, not recruitingNCT07828171Updated Sep 18, 2026

Evaluation of Efficacy of Antibacterial Activity of Licorice, Clove, and Chlorohexidine Mouthwashes on Salivary Streptococcus Mutans in a Group of Egyptian Children.

An interventional study of Mouth wash in Dental Caries, Streptococcal Infections and Mouthwashes, sponsored by British University In Egypt. Active, not recruiting at 1 site in Egypt. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by British University In Egypt · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Oct 2025, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 205 studies in Dental Caries with a site in Egypt — 47 open to participants now, 67 under way, 1 of them phase 3. Dental Caries · Egypt.

Planned enrollment
70th of 179
54 · median 44
Started
2025
with 31 others
No phase
153 of 205
36 open now
Primary completion
2027-01
later than 53 of 66 live
Registered
201st of 205
by date

Among the 205 studies in Dental Caries with a site in Egypt, this one is the 70th largest by planned enrollment of the 179 interventional ones, is one of 32 that started in 2025, is one of 153 with no phase, reaches primary completion later than 53 of the 66 other live ones, and was the 201st registered.

By phase

205 studies; the count open now beside each. This study's row is marked.

No phasethis study153 · 36 open
Observational26 · 10 open
Phase 49 · 0 open
Phase 36 · 0 open
Phase 25 · 1 open
Phase 13 · 0 open
Phase 2/32 · 0 open
Phase 1/21 · 0 open

By the year they started

First in 2011; this study’s year is marked. 32 started in 2025.

Size and results

Median enrollment 44 across the 179 interventional studies, 219 across the 26 observational. Of the 103 that completed or were terminated, 2 (2%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 205 studies in Dental Caries with a site in Egypt, or all of them as a file.
02

Study summary

A randomized controlled trial that compares the antibacterial effectiveness of three mouthwashes-licorice, clove, and chlorhexidine-in Egyptian children aged 7-12 years.

The main focus is Streptococcus mutans, one of the main bacteria associated with dental caries. The saliva samples will be collected from the children and the amount of S. mutans will be measured before and after using the assigned mouthwash.

The children will be randomly divided into groups, with each group receiving one of the three mouthwashes. The bacterial counts will then be compared to determine which mouthwash is most effective at reducing salivary S. mutans.

The research question is whether natural mouthwashes made from licorice or clove reduce the bacteria that cause cavities as effectively as chlorhexidine in children?

The study could help determine whether licorice and clove are effective natural alternatives or adjuncts to chlorhexidine, particularly considering that chlorhexidine can have undesirable effects with prolonged use.

Overall aim: Compare and evaluate the antibacterial efficacy of the three mouthwashes

03

Conditions studied

  • Dental Caries
  • Streptococcal Infections
  • Mouthwashes
04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients with high caries index based on CAMBRA.
  • Frankl scale 3 and 4 (cooperative).

Exclusion criteria

Exclusion Criteria:

  • Patients with teeth showing signs of infection (abscess or fistula)
  • Patients with mucositis (can't be given alcohol containing mouthwashes)
  • Hypertensive patients.
  • Allergic patients.
  • Special health care patients.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
54 participants (estimated)

Study arms

  • Active comparator
    Chlorohexidine Mouthwash

    Other: Mouth wash

  • Experimental
    Clove mouthwash

    Other: Mouth wash

  • Experimental
    Licorice mouthwash

    Other: Mouth wash

Interventions

  • OtherMouth wash

    The interventions will consist of three different mouthwashes: licorice mouthwash, clove mouthwash, and 0.2% chlorhexidine mouthwash. Each participant will use the mouthwash assigned to their study group according to the standardized study protocol. The herbal mouthwashes will be prepared using standardized licorice and clove extracts at predetermined concentrations, while the chlorhexidine group will receive 0.2% chlorhexidine mouthwash as the positive control. All mouthwashes will be provided in identical, appropriately labeled containers to maintain blinding where applicable. The interventions will be distinguished by their active ingredient and concentration, while the method, frequency, duration of use, and volume administered will be standardized across all groups.

06

What researchers measure

Primary outcomes

  1. Reduction of dental caries incidence in high-caries index pediatric patients using International Caries Detection and Assessment System.

    Time frame: Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.

Secondary outcomes

  1. The reduction in Streptococcus mutans count following the use of licorice and clove mouthwashes in Egyptian pediatric patients aged from 7 to 12.

    Time frame: Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.

  2. Patient reported satisfaction, regarding the taste using a questionnaire.

    Time frame: Through study completion, an average of 3 months.

  3. Adverse events related to the use of the licorice and clove mouthwashes, regarding oral irritation and allergies using a questionnaire.

    Time frame: Through study completion, an average of 3 months.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Jan 2027, 15 months after the start.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 15 months is close to that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 7, 2026
First posted
Sep 18, 2026
StartActual
Oct 6, 2025
Primary completionEst.
Jan 2027
CompletionEst.
Jun 2027
Last update
Sep 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07828171
Lead sponsor
British University In Egypt
Responsible party
PG NADINE (Primary investigator, British University In Egypt) — Principal investigator
First posted
Sep 18, 2026
Start date
Oct 6, 2025
Primary completion
Jan 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Sep 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion